Aarti Industries posted a 23.3% surge in consolidated net profit to Rs 136.10 crore on 12.4% rise in net sales to Rs 1209.35 crore in Q4 FY21 over Q4 FY20.The chemical maker saw sustained revenue growth driven by volume expansion and 75% contribution from value-added products. The company said that demand for discretionary products has majorly returned to pre-covid levels. The pharma segment revenues were at record levels, profitability sustained as the product basket remains focused on value addition.
Profit before tax grew by 27.2% to Rs 173.05 crore in Q4 FY21 over Q4 FY20. EBITDA rose 18.9% year on year to Rs 260 crore in Q4 FY21. EBITDA margin improved to 19.3% in Q4 FY21 from 18.4% in Q4 FY20. The company added that gross margins have returned to normalized levels.